Method Eases Making Amino Acids Critical In Medicinal Chemistry

May 02, 1997

CHAMPAIGN, Ill. - The synthesis of both left- and right-handed versions (enantiomers) of alpha-, beta- and gamma- (aryl) amino acids is the latest application of a new chemical methodology developed by a chemist at the University of Illinois.

"The importance of both natural and unnatural amino acids to medicinal and biological chemistry has made these compounds a focal point for chemical synthesis," said Peter Beak, a U. of I. professor of chemistry. "We have demonstrated that our methodology will produce both enantiomers of three types of aryl amino acids more efficiently and more conveniently than conventional techniques."

Amino acids ­ like many organic molecules ­ exhibit a particular "handedness," or chirality. The two resulting structures, called enantiomers, are analogous to a pair of hands: They form nonsuperimposable mirror images of each other. The reactions of chiral compounds are highly structure dependent, just as the right hand of one person requires the right hand of another to perform a handshake. Thus, the correct chirality must be built into a synthesized biomolecule.

"Our chemistry begins with a molecule that is superimposable on its mirror image, and converts it into an aryl amino acid that is nonsuperimposable on its mirror image," Beak said. "Our yields are high, depending upon the reagent being used and the type of amino acid being produced."

Beak's methodology, developed in collaboration with Yong Sun Park, a postdoctoral research associate, uses a process of transient molecular bonding called chiral ligand binding. In this synthetic approach, an auxiliary molecule ­ the ligand ­ binds to a lithium ion, which is associated with an amine derivative present in the solution, to make a complex. Because the ligand is chiral, it also imparts the correct "handedness" to subsequent reactions.

"The key to our technique is the association between the lithium ion and the chiral ligand in a critical step," Beak said. "By carrying out the lithiation and substitution in the presence of the chiral ligand and selecting the appropriate reagents, we are able to generate a product that is highly enriched in either of the two enantiomers of the desired amino acid."

The production of unnatural amino acids is of particular interest to the pharmaceutical industry, Beak said. "Nature uses only one enantiomer of amino acids in the construction of enzymes and proteins. The metabolism of the human body has developed ways to break these down. By placing an unnatural amino acid in biologically active molecules, the stability of a possible drug can be significantly enhanced."

In addition to synthesizing enantiomers of aryl amino acids, Beak also has used his chiral ligand chemistry to create a variety of enantioenriched acids, amides, amines and aldehydes. Beak's latest research results were published in the March 21 issue of the Journal of Organic Chemistry.
-end-


University of Illinois at Urbana-Champaign

Related Amino Acids Articles from Brightsurf:

Igniting the synthetic transport of amino acids in living cells
Researchers from ICIQ's Ballester group and IRBBarcelona's Palacín group have published a paper in Chem showing how a synthetic carrier calix[4]pyrrole cavitand can transport amino acids across liposome and cell membranes bringing future therapies a step closer.

Microwaves are useful to combine amino acids with hetero-steroids
Aza-steroids are important class of compounds because of their numerous biological activities.

New study finds two amino acids are the Marie Kondo of molecular liquid phase separation
a team of biologists at the Advanced Science Research Center at The Graduate Center, CUNY (CUNY ASRC) have identified unique roles for the amino acids arginine and lysine in contributing to molecule liquid phase properties and their regulation.

Prediction of protein disorder from amino acid sequence
Structural disorder is vital for proteins' function in diverse biological processes.

A natural amino acid could be a novel treatment for polyglutamine diseases
Researchers from Osaka University, National Center of Neurology and Psychiatry, and Niigata University identified the amino acid arginine as a potential disease-modifying drug for polyglutamine diseases, including familial spinocerebellar ataxia and Huntington disease.

Alzheimer's: Can an amino acid help to restore memories?
Scientists at the Laboratoire des Maladies Neurodégénératives (CNRS/CEA/Université Paris-Saclay) and the Neurocentre Magendie (INSERM/Université de Bordeaux) have just shown that a metabolic pathway plays a determining role in Alzheimer's disease's memory problems.

New study indicates amino acid may be useful in treating ALS
A naturally occurring amino acid is gaining attention as a possible treatment for ALS following a new study published in the Journal of Neuropathology & Experimental Neurology.

Breaking up amino acids with radiation
A new experimental and theoretical study published in EPJ D has shown how the ions formed when electrons collide with one amino acid, glutamine, differ according to the energy of the colliding electrons.

To make amino acids, just add electricity
By finding the right combination of abundantly available starting materials and catalyst, Kyushu University researchers were able to synthesize amino acids with high efficiency through a reaction driven by electricity.

Nanopores can identify the amino acids in proteins, the first step to sequencing
While DNA sequencing is a useful tool for determining what's going on in a cell or a person's body, it only tells part of the story.

Read More: Amino Acids News and Amino Acids Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.